These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7035136)

  • 21. [Effect of chloramphenicol against different E. coli strains in vitro and in experimental pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1968 Sep; 18(9):1123-7. PubMed ID: 4885372
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental pyelonephritis in rats.
    Mehrotra RM; Pande CL; Chaturvedi UC
    Indian J Med Res; 1976 Mar; 64(3):459-71. PubMed ID: 786871
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of active immunisation on ascending pyelonephritis in the rat.
    Radford NJ; Chick S; Ling R; Coles GA; Asscher AW
    J Pathol; 1974 Mar; 112(3):169-75. PubMed ID: 4601025
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bacterial phagocytosis of the proximal convoluted tubules in experimental pyelonephritis].
    Iványi B; Krenács T; Petri S; Lantos J
    Morphol Igazsagugyi Orv Sz; 1986 Jan; 26(1):25-32. PubMed ID: 3512980
    [No Abstract]   [Full Text] [Related]  

  • 25. Mouse model for pyelonephritis.
    Tittel AP; Heuser C; Kurts C
    Curr Protoc Immunol; 2013; Chapter 15():Unit 15.23.1-9. PubMed ID: 23564687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escherichia coli virulence and renal scarring.
    Topley N; Mackenzie RK; Steadman R; Williams JD
    J Infect Dis; 1989 Dec; 160(6):1081-3. PubMed ID: 2685127
    [No Abstract]   [Full Text] [Related]  

  • 27. Local production of inflammatory mediators in an experimental model of acute obstructive pyelonephritis.
    Kaboré AF; Simard M; Bergeron MG
    J Infect Dis; 1999 May; 179(5):1162-72. PubMed ID: 10191219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental production of pyeloureteritis cystica and glandularis.
    Hill GS
    Invest Urol; 1971 Jul; 9(1):1-9. PubMed ID: 4935214
    [No Abstract]   [Full Text] [Related]  

  • 29. [Scanning electron microscopic study of experimental pyelonephritis].
    Iványi B; Farkas Z; Bohus K; Lantos J; Ormos J
    Morphol Igazsagugyi Orv Sz; 1984 Apr; 24(2):81-7. PubMed ID: 6371499
    [No Abstract]   [Full Text] [Related]  

  • 30. Melatonin prevents neutrophil-mediated oxidative injury in Escherichia coli-induced pyelonephritis in rats.
    Sener G; Tuğtepe H; Velioğlu-Oğünç A; Cetinel S; Gedik N; Yeğen BC
    J Pineal Res; 2006 Oct; 41(3):220-7. PubMed ID: 16948782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strain-dependent difference in susceptibility of mice to experimental ascending pyelonephritis.
    Guze PA; Kalmanson GM; Ishida K; Guze LB
    J Infect Dis; 1987 Sep; 156(3):523-5. PubMed ID: 3112242
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary pyelonephritis (the focal problem)].
    Rényi-Vámos F; Balogh F
    Z Urol Nephrol; 1979 Aug; 72(8):581-8. PubMed ID: 388921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of parenteral iron preparations on experimental pyelonephritis.
    Fletcher J; Goldstein E
    Br J Exp Pathol; 1970 Jun; 51(3):280-5. PubMed ID: 4913857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal scarring and non-attaching Escherichia coli.
    Lomberg H; Hellström M; Jodal U; Svanborg-Edén C
    Lancet; 1986 Dec; 2(8519):1341. PubMed ID: 2878215
    [No Abstract]   [Full Text] [Related]  

  • 35. Bilateral renal abscessation and chronic active pyelonephritis in a male camel (Camelus dromedarius) caused by Escherichia coli.
    Tharwat M; Sadan M; El-Shafaey ES; Saeed EH; Al-Hawas A
    J Vet Med Sci; 2018 May; 80(5):778-783. PubMed ID: 29563349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative studies on hematogenous and ascending pyelonephritis in rats].
    Adler CP; Ritzmann H; Zollinger HU
    Virchows Arch A Pathol Pathol Anat; 1969; 347(4):277-95. PubMed ID: 4896845
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunization against retrograde pyelonephritis. III. Vaccination against chronic pyelonephritis due to Escherichia coli.
    Brooks SJ; Lyons JM; Braude AI
    J Infect Dis; 1977 Nov; 136(5):633-9. PubMed ID: 335001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyelonephritis XV. Long-term study of ascending Escherichia coli pyelonephritis in mice.
    Kalmanson GM; Montgomerie JZ; Hubert EG; Barajas L; Guze LB
    Yale J Biol Med; 1973 Jun; 46(3):196-202. PubMed ID: 4611056
    [No Abstract]   [Full Text] [Related]  

  • 39. Contributions to the development of experimental pyelonephritis.
    Ormos J; Csapó Z; Lantos J
    Acta Morphol Acad Sci Hung; 1968; 16(1):85-101. PubMed ID: 4879357
    [No Abstract]   [Full Text] [Related]  

  • 40. Endogenous tissue-type plasminogen activator is protective during ascending urinary tract infection.
    Roelofs JJ; Rouschop KM; Teske GJ; Wagenaar GT; Claessen N; Weening JJ; van der Poll T; Florquin S
    Nephrol Dial Transplant; 2009 Mar; 24(3):801-8. PubMed ID: 18842674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.